Asbrink E, Hovmark A
Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):161-3. doi: 10.1111/j.1699-0463.1985.tb02870.x.
Spirochetes could be cultivated from 9 out of 13 skin biopsies from patients with erythema chronicum migrans Afzelius (ECMA) and from 2 out of 5 biopsies from patients with acrodermatitis chronica atrophicans (ACA) by using a newly modified serumless Kelly's medium. The different spirochete strains grew best at a low oxygen tension. Attempts to grow spirochetes from blood and cerebrospinal fluid failed. The cultivation of spirochetes from secondary ECMA lesions favours the presumption that a spirochetemia may occur in ECMA. The isolation of spirochetes from an ACA patient who had a disease duration of greater than 10 years proves that the spirochetes may survive in the human body for a considerable time.
通过使用新改良的无血清凯利培养基,从13例慢性游走性红斑阿费利乌斯(ECMA)患者的皮肤活检样本中,有9例培养出了螺旋体;从5例进行性色素性紫癜性皮病(ACA)患者的活检样本中,有2例培养出了螺旋体。不同的螺旋体菌株在低氧张力下生长最佳。从血液和脑脊液中培养螺旋体的尝试均告失败。从继发性ECMA病变中培养出螺旋体,支持了ECMA可能发生螺旋体血症的推测。从一名病程超过10年的ACA患者中分离出螺旋体,证明螺旋体可能在人体内存活相当长的时间。